Makary Plans To Review Mifepristone Data, Raising Concerns Of Abortion Pill Access Rollbacks

 
• By Sarah Karlin-Smith
  
The Senate HELP Committee questioned FDA Commissioner nominee Martin Makary on 6 March. (Screenshot of Senate Broadcast)

More from US FDA

More from Geography